Form 8-K Baudax Bio, Inc. For: Feb 22
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Caribou Biosciences to halt CAR-T programs, explore sale
- Stryker names Spencer Stiles as CEO, Lobo moves to chair
- Francis Halzen wins Nobel physics prize for Antarctic 'ghost particle' hunt
Baudax Bio (BXRX) Files Chapter 11
February 28, 2024 6:17 AM ESTOn February 22, 2024, Baudax Bio (NASDAQ: BXRX) filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy code (the Bankruptcy Code) in the U.S. Bankruptcy Court for the Eastern District of Pennsylvania (the Bankruptcy Court) (the Chapter 11 Case). The Chapter 11 Case was assigned case number... More



